News

OSLO, NORWAY – 25 November 2024: Genetic Analysis AS (“GA” or “the Company”) announces that members of the management has…

OSLO, NORWAY – 15 November 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the third…

OSLO, NORWAY – 30 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim…

OSLO, NORWAY – 15 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces the launch of…

OSLO, NORWAY – August 8, 2024: Microbiome DX company Genetic Analysis AS (“GA”) announces the completion and launch of a…

Oslo, Norway, July 17, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held an Extraordinary General Meeting today, July…

OSLO, NORWAY – July 15, 2024: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that the…

OSLO, NORWAY – 04 July 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…

Oslo, Norway, July 3, 2024 – Notice is hereby served that an extraordinary general meeting of Genetic Analysis AS (the…

Genetic Analysis AS (“GA” or the “Company”) is pleased to announce that it has successfully placed a directed issue and…

OSLO, NORWAY – 13 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today the grant…

OSLO, NORWAY – 3 June 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board…

OSLO, NORWAY – 31 May 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board…